Physician profile
Hannah Carpenter
NPI 1689419855
$2,894.44
in general payments reported to CMS, 2019-2025
19 companies · $2,431 in 2025
The $2,431 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $463 · 2025: $2,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,894.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $743.78 | 2024-2025 | Rezdiffra, Resmetirom |
| Abbvie INC. | $557.98 | 2024-2025 | |
| Ardelyx, INC. | $255.28 | 2024-2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $235.81 | 2024-2025 | Voquezna |
| Janssen Biotech, INC. | $201.97 | 2025 | Tremfya, Simponi Aria, Stelara |
| Dexcom, INC. | $165.44 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Takeda Pharmaceuticals U.S.A., INC. | $114.28 | 2024-2025 | Entyvio |
| Glaxosmithkline, LLC. | $103.67 | 2025 | |
| Gilead Sciences, INC. | $98.86 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $85.97 | 2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $83.16 | 2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.55 | 2025 | Xifaxan |
| Celltrion USA INC. | $38.24 | 2024 | Vegzelma |
| Aimmune Therapeutics, INC. | $36.38 | 2025 | Vowst, Zenpep |
| Qol Medical, LLC | $33.75 | 2025 | Sucraid |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $29.75 | 2025 | Wegovy |
| Abbott Laboratories | $28.10 | 2025 | Amplatzer Amulet |
| Pfizer INC. | $15.50 | 2024 | |
| Intercept Pharmaceuticals, INC. | $14.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.